CRT-100.06 Ticagrelor After Pharmacological Thrombolysis in Patients With ST-Segment Elevation Myocardial Infarctions: An Insight From a Trial Sequential Analysis

Few randomized controlled trials (RCTs) have compared ticagrelor to clopidogrel after thrombolytic therapy in patients with ST-segment elevation myocardial infarction (STEMI). To assess the quality of the current evidence, a trial sequential analysis (TSA) of all the available RCTs was performed. A